P
PRQR
Proqr Therapeuti
1.560
+0.120+8.33%After Hours: 1.540 -0.020 -1.28%19:14 05/22 EDT
OPEN/PREV CLOSE1.450/1.440
TODAY RANGE1.450-1.575
VOL552.64K
MARKET CAP164.37M
52 WEEK RANGE1.330-3.100
AVG VOL (3M)577.56K
% TURNOVER0.52%
TURNOVER--
P/E (TTM)-3.1306
% RANGE8.33%
EPS(TTM)-0.4983
P/E(FORWARD)-2.6087
P/B3.872
BVPS0.4029
DIVIDEND--
P/S8.75
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP135.33M
SHARES OUTSTANDING105.36M
NEXT EARNINGS08/05-08/10
FREE FLOAT86.75M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·05/12 11:57
ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances
TipRanks·05/12 11:56
ProQR Posts Wider Q1 2026 Loss but Maintains Strong Cash Position
Benzinga·05/12 11:13
ProQR Therapeutics Q1 EPS $(0.15), Inline, Sales $2.381M Miss $5.530M Estimate
Seeking Alpha·05/12 11:09
ProQR GAAP EPS of -€0.13, revenue of €2.03M
Reuters·05/12 11:09
ProQR Therapeutics Q1 revenue falls and misses estimates
Reuters·05/12 11:00
BRIEF-ProQR Therapeutics Q1 EPS EUR -0.13
Reuters·05/07 20:58
Ginkgo Bioworks Q1 revenue falls 49% on restructuring
TipRanks·05/04 12:27
ProQR Sets June 2, 2026 Date for Annual General Meeting of Shareholders
PUBT·05/04 12:06
ProQR Therapeutics announces annual shareholder meeting